Your Search
Sort Options
Search results
Pages
![The cancer burden in the oldest-old: Increasing numbers and disparities-A nationwide study in the Netherlands, 1990 to 2019](/sites/all/themes/scholarly/img/closed_access.png?solr_nav%5Bid%5D=75461ef2325088381053&solr_nav%5Bpage%5D=0&solr_nav%5Boffset%5D=3)
![Oncogene-addicted metastatic non-small-cell lung cancer](/sites/all/modules/custom/islandora_solr_search/images/defaultimg.png?solr_nav%5Bid%5D=75461ef2325088381053&solr_nav%5Bpage%5D=0&solr_nav%5Boffset%5D=7)
- •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing oncogene-addicted mNSCLC.
- •ESMO-MCBS scores are given to describe the levels of evidence for treatment...
- •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing oncogene-addicted mNSCLC.
- •ESMO-MCBS scores are given to describe the levels of evidence for treatment choices.
- •ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.
- •Recommendations are based on available scientific data and the authors’ collective expert opinion.
- •In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach
- •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing non-oncogene-addicted mNSCLC.
- •ESMO-MCBS scores are given to describe the levels of evidence for...
- •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing non-oncogene-addicted mNSCLC.
- •ESMO-MCBS scores are given to describe the levels of evidence for treatment choices.
- •ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.
- •Recommendations are based on available scientific data and the authors’ collective expert opinion.
- •In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach.
![Editorial: Glucocorticoid and bone: Friend or foe](/sites/all/modules/custom/islandora_solr_search/images/defaultimg.png?solr_nav%5Bid%5D=75461ef2325088381053&solr_nav%5Bpage%5D=0&solr_nav%5Boffset%5D=17)
![Effects of Oral Health Interventions in People with Oropharyngeal Dysphagia: A Systematic Review](/sites/all/modules/custom/islandora_solr_search/images/defaultimg.png?solr_nav%5Bid%5D=75461ef2325088381053&solr_nav%5Bpage%5D=0&solr_nav%5Boffset%5D=19)